Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2017
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy
Himisha Beltran, Alexander W Wyatt, Edmund C Chedgy, et al.
Oncotarget
|
December 30, 2014
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
Dong Lin, Xin Dong, Kendric Wang, et al.
Genes, Chromosomes & Cancer
|
August 29, 2012
Poly-gene fusion transcripts and chromothripsis in prostate cancer
Chunxiao Wu, Alexander W Wyatt, Andrew McPherson, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
AR-V7 condensates drive androgen-independent transcription in castration resistant prostate cancer
Shabnam Massah, Nicholas Pinette, Jane Foo, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational Status
Madison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2017
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Gillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, et al.
Clinical Epigenetics
|
February 16, 2016
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
Pier-Luc Clermont, Francesco Crea, Yan Ting Chiang, et al.
Cancer Research
|
March 1, 2018
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer
Xinpei Ci, Jun Hao, Xin Dong, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
Yoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, et al.
Translational Oncology
|
November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations
Nelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2017
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy
Himisha Beltran, Alexander W Wyatt, Edmund C Chedgy, et al.
Oncotarget
|
December 30, 2014
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
Dong Lin, Xin Dong, Kendric Wang, et al.
Genes, Chromosomes & Cancer
|
August 29, 2012
Poly-gene fusion transcripts and chromothripsis in prostate cancer
Chunxiao Wu, Alexander W Wyatt, Andrew McPherson, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
AR-V7 condensates drive androgen-independent transcription in castration resistant prostate cancer
Shabnam Massah, Nicholas Pinette, Jane Foo, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational Status
Madison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2017
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Gillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, et al.
Clinical Epigenetics
|
February 16, 2016
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
Pier-Luc Clermont, Francesco Crea, Yan Ting Chiang, et al.
Cancer Research
|
March 1, 2018
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer
Xinpei Ci, Jun Hao, Xin Dong, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
Yoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, et al.
Translational Oncology
|
November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations
Nelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Page
of 10